Intravenous Recombinant Tissue Plasminogen Activator Improves Arterial Recanalization Rates and Reduces Infarct Volumes in Patients With Hyperdense Artery Sign on Baseline Computed Tomography

Journal of Stroke and Cerebrovascular Diseases

Volumn 17, Issue 2, 2008, Pages 64-68

  Nichols, Christopher ^a   Khoury, Jane ^a   Brott, Thomas ^b   Broderick, Joseph ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Acute stroke; hyperdense artery; recanalization; stroke volume; tissue plasminogen activator

Indexed keywords

PLACEBO; RECOMBINANT PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BRAIN INFARCTION SIZE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECANALIZATION; STROKE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CEREBRAL ANGIOGRAPHY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UNITED STATES;

EID: 40749151479     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2007.10.002     Document Type: Article

References (23)

1. Gacs G., Fox A.J., Barnett H.J., et al. CT visualization of intracranial arterial thromboembolism. Stroke 14 (1983) 756-762
2. Tomsick T.A., Brott T.G., Olinger C.P., et al. Hyperdense middle cerebral artery: Incidence and quantitative significance. Neuroradiology 31 (1989) 312-315
3. Bastianello S., Pierallini A., Colonnese C., et al. Hyperdense middle cerebral artery CT sign: Comparison with angiography in the acute phase of ischemic supratentorial infarction. Neuroradiology 33 (1991) 207-211
4. Leys D., Pruvo J.P., Godefroy O., et al. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 23 (1992) 317-324
5. Kim E.Y., Lee S.K., Kim D.J., et al. Detection of thrombus in acute ischemic stroke: Value of thin-section noncontrast-computed tomography. Stroke 36 (2005) 2745-2747
6. Manelfe C., Larrue V., von Kummer R., et al. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 30 (1999) 769-772
7. Agarwal P., Kumar S., Hariharan S., et al. Hyperdense middle cerebral artery sign: Can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?. Cerebrovasc Dis 17 (2004) 182-190
8. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
9. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. Stroke 31 (2000) 2912-2919
10. Qureshi A.I., Ezzeddine M.A., Nasar A., et al. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?. Neurology 66 (2006) 1171-1174
11. Patel S.C., Levine S.R., Tilley B.C., et al. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 286 (2001) 2830-2838
12. del Zoppo G.J., Poeck K., Pessin M.S., et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32 (1992) 78-86
13. Alexandrov A.V., Demchuk A.M., Felberg R.A., et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 31 (2000) 610-614
14. Alexandrov A.V., Demchuk A.M., Burgin W.S., et al., CLOTBUST Investigators. Ultrasound-enhanced thrombolysis for acute ischemic stroke, phase I: Findings of the CLOTBUST trial. J Neuroimaging 14 (2004) 113-117
15. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The interventional management of stroke study. Stroke 35 (2004) 904-911
16. Lee K.Y., Han S.W., Kim S.H., et al. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. Stroke 38 (2007) 192-193
17. Hacke W., Albers G., Al-Rawi Y., et al., DIAS Study Group. The desmoteplase in acute ischemic stroke trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36 (2005) 66-73
18. Furlan A.J., Eyding D., Albers G.W., et al., DEDAS Investigators. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37 (2006) 1227-1231
19. Aronowski J., Strong R., and Grotta J.C. Reperfusion injury: Demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab 17 (1997) 1048-1056
20. Molina C.A., Alvarez-Sabin J., Montaner J., et al. Thrombolysis-related hemorrhagic infarction: A marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 33 (2002) 1551-1556
21. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke, the PROACT II study: A randomized controlled trial, prolyse in acute cerebral thromboembolism. JAMA 282 (1999) 2003-2011
22. Gobin Y.P., Starkman S., Duckwiler G.R., et al. MERCI 1: A phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 35 (2004) 2848-2854
23. Smith W.S. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke: Results of the multi mechanical embolus removal in cerebral ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 27 (2006) 1177-1182